human MS lesions
progressive MS patients
MS tissue available
Multiple Sclerosis Lesions
importance of innovative MS research
remyelination
multidisciplinary project
stages of OL differentiation
repair mechanisms of individual MS patients
patterns of OL differentiation
Single Cell RNA-Sequencing
single nuclear RNA-sequencing
MuSeq
Edinburgh tissue bank
scRNA-seq
snRNA-seq
future career
new therapies
University of Edinburgh
Oligodendrocyte Lineage
possible stages
world-leading medical research institution
future functional studies
human post-mortem brain
Current neuropathological technologies
guidance of leading experts
open-access web database
failure
independent researcher
powerful classification system
antibody labelling
secondment
Stockholm
time
field of translational neuroscience
rational therapeutics
Karolinska Institute
motivation
foundations
degree of heterogeneity
European scientific excellence
public awareness
regenerative potential
track-record
expertise
way
laboratory
problems of sensitivity
process
turn
extra skills
key roadblocks
neurodegeneration
Results